Form 8-K - Current report:
SEC Accession No. 0001104659-25-004565
Filing Date
2025-01-17
Accepted
2025-01-17 17:24:07
Documents
17
Period of Report
2025-01-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253736d1_8k.htm   iXBRL 8-K 31434
2 EXHIBIT 3.1 tm253736d1_ex3-1.htm EX-3.1 1335
3 EXHIBIT 99.1 tm253736d1_ex99-1.htm EX-99.1 10474
7 GRAPHIC tm253736d1_ex3-1img01.jpg GRAPHIC 549719
8 GRAPHIC tm253736d1_ex3-1img02.jpg GRAPHIC 85045
  Complete submission text file 0001104659-25-004565.txt   1077389

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mbio-20250114.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20250114_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20250114_pre.xml EX-101.PRE 22363
19 EXTRACTED XBRL INSTANCE DOCUMENT tm253736d1_8k_htm.xml XML 3678
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 25539643
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)